Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05FGN
|
|||
| Drug Name |
DFV890
|
|||
| Drug Type |
Protein/peptide drug
|
|||
| Indication | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Phase 2 | [1] | |
| Therapeutic Class |
Antiviral Agents
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04382053) Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.